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Abstract
The stress response is a natural reaction by the body, against potentially harmful stimuli to enhance
the chance for survival. Persistent activation of the stress response can cause changes to
homeostatic mechanisms. The study of stress neurophysiology, in the evaluation of the
manifestation of disease in the body, suggests that these chronic changes have detrimental effects
on sub cortical structures. Furthermore, there is much scientific support for the notion that
chronic activation of supraspinal systems will lead to maladaptation of homeostatic mechanisms,
causing the impairment of processes within the body, and ultimately leading to visceral disorders.
The chiropractic profession for many years has alluded to chronic change of neurophysiological
pathways as a potential explanation of visceral disorders, but the profession has typically described
these in terms of somatovisceral or viscerosomatic reflex activity. Change in supraspinal
neurophysiological efferent activity is increasingly being used to explain "stress" related disease.
The chiropractic profession should consider investigating such stress responses by conducting
spinal manipulative therapy trials that evaluate supraspinal effects of manipulation. Such research
may help elucidate key mechanisms associated with the change of visceral disorders noted by some
chiropractors following manipulative therapy.
Background
Walter Canon offered the first model of homeostasis as
the "coordinated physiological processes which maintain
most of the steady states in the organism" [1-3], and fur-
ther focused on the "sympathetic nervous system as an
essential homeostatic system that served to restore stress-
induced disturbed homeostasis and to promote survival
of the organism". From work conducted during the 1930's
to 1950's, Hans Selye introduced the concept of stress as a
medical and scientific entity, depicting a pathological
triad elicited by numerous stressors. Sleye then employed
this defined theory of stress as "the non-specific response
of the body to any demand" [4]. Selye proposed that the
human body had a finite amount of adaptable energy,
and opined that a stressor whether pleasant or not, was
irrelevant because any type of stress required adaptation
to manifest. The important criterion was the intensity of
the demand, and whether the body could meet that
demand with an appropriate response. This cognitive
response came to be known as the "fight-or-flight"
response [5] and involved the activation of necessary
physiological and behavioral responses for survival [6].
These responses are often referred to as 'stress responses'
and include the activation of the hypothalamic-pituitary-
adrenal axis and sympatho-adrenal system, resulting in
the consequential secretion of multiple hormones includ-
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ing corticotrophin releasing hormone, adrenocorticotro-
pin hormone, cortisol, norepinephrine and epinephrine
[7]. Once the stress response is activated, behavioral and
physiological changes lead the way for the organism to
adjust homeostasis within the body, and increase its
chances for survival [8].
It is in times of sustained or repeated activation that the
stress response may alter [7]. Due to the intricate nature of
the above systems, systematic changes can cause dramatic
effects on organs, which otherwise would be activated in
advantage for the organism [9]. Repeated stimulation of
hormones, and neurotransmitters may render target tis-
sues resistant, instigating the cascade into disease and ill-
ness [10]. Many pathological processes, such as chronic
pain disorders, immune disorders, cardiovascular disor-
ders, metabolic disease and behaviour disorders, may be
the result of chronic activation of the hypothalamo-pitui-
tary-adrenal axis and sympatho-adrenal system, affecting
tissues or biological pathways, contributing to the global
nature of disease [11,12].
As stress becomes more prominent in society, trying to
understand mechanisms with which it manifests in the
body, and potential treatment for these manifestations is
imperative to the development of effective chiropractic
treatment strategies. This commentary attempts to address
the development of disease within in the body due to
chronic stress activation. It discusses the anatomy, physi-
ology and the relationship of adverse chronic stress activa-
tion on systems within the body. This is followed by
discussion of how these variables integrate and are poten-
tially affected by the application of manipulative therapy.
Discussion
Neuroanatomy
This section will outline the neuroanatomy of the stress
response, focusing on input and output pathways. As
there are multiple brain structures concerned in the organ-
ization of the stress response, these systems are intricately
related. A schematic representation of the stress system is
presented in Figure 1.
Hypothalamic afferents
Nearly all stress-related information projected to the
hypothalamus is congregated to the lateral hypothalamus,
where combinations of numerous ascending and
descending fibres are integrated from areas including the
limbic system, medial hypothalamus, and the autonomic
nervous system containing with thousands of interneu-
rons [13].
Numerous viscerosensory signals arise from glossopharyn-
geal (IX) and vagal (X) cranial nerves in the spinal cord
and from the lower brain stem, which project to the
nucleus of the solitary tract (NTS), and terminate via mul-
tisynaptic pathways at the hypothalamus [14]. The NTS is
the first region in the central nervous system that proc-
esses information about visceral, cardiovascular, respira-
tory functions as well as taste. Neurons of the NTS project
to the paraventricular nucleus, and other hypothalamic
nuclei among other destinations [15]. The NTS has other
viscerosensory fibres terminating on catecholaminergic
neurons, which then project to the hypothalamus [14].
Somatosensory signals reach the hypothalamus directly via
the spinohypothalamic tract [16], by axon collaterals of
fibres of the spinoreticulothalamic and/or spinothalamic
tracts in the spinal dorsal horn [17], or through the activa-
tion of the brainstem catecholaminergic system [14].
Ascending medullary viscero- and somato-sensory neu-
rons have been associated as carriers of autonomic signals
to the hypothalamus. Signals may directly project to the
hypothalamus, or indirectly through secondary auto-
nomic centres, such as the parabrachial nuclei [13].
Hypothalamic efferents
The output system involves the recognition of the stress
response, and engages both the neuroendocrine and neu-
ronal pathways [13]. The higher centres consisting of the
cerebral cortex, limbic system and hypothalamus are neu-
ronally connected with the brain stem, autonomic and
sensory centres, as well as interconnected with each other.
The higher centres do not have connections to the periph-
ery, though they are able to indirectly and bilaterally influ-
ence sympathetic and parasympathetic preganglionic
neurons via the efferent paraventricular pathway [18].
The hypothalamus is able to exert effects via neurohu-
moral pathways through the pituitary, autonomic effects
via neuronal pathways to preganglionic neurons, and able
to exert both parasympathetic and sympathetic effects
through the medulla oblongata and spinal cord [14].
The four predominant nuclei containing descending
hypothalamic-autonomic fibres include the paraventricu-
lar, arcuate, perifornical and dorso-lateral hypothalamic
nuclei. The hypothalamic paraventricular nucleus (PVN)
is a central site in the complex of interacting systems con-
trolling the stress response [19]. It is the foremost source
of descending hypothalamic pathways to autonomic cen-
tres, with fibres arising from dorsal, posterior and lateral
parvicellular subgroups containing a variety of putative
neurotransmitters. Toth et al. [20] investigated the decus-
sations of descending fibres of the PVN by using vulgaris-
leucoagglutinin in intact brain stem operated rats. Par-
aventricular fibres descend by the length of the brainstem
and spinal cord via two descending tracts: one from the
lateral hypothalamus, along the lateral lemniscus and
from the pons, moving ventrolaterally and running intoChiropractic & Osteopathy 2006, 14:25 http://www.chiroandosteo.com/content/14/1/25
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the ventrolateral medulla. Some of these fibres loop dor-
somedially in the caudal ventrolateral medulla to inner-
vate the NTS, and dorsal motor nucleus of the vagus nerve
(X). Secondary fibres run periventicularly and join the
above tract at the pontine level [21]. Toth et al. [20] found
descending fibres of the PVN decussate supramamillary,
at the pontine tegmentum, at the commissural part of the
NTS (major cross over area), and at Lamina X of the tho-
racic spinal cord levels. Termination of these pathways
has been confirmed in the NTS [22], A1/C1 catecholamin-
ergic cell groups [18], pre-sympathetic (rostroventrola-
teral) medulla and sympathetic (IML) neurons [23]. The
A schematic representation of the stress response Figure 1
A schematic representation of the stress response. CRH, corticotrophin releasing hormone; AVP, arginine vasopressin; ACTH: 
adrenocorticotrophin releasing hormone, E: epinephrine, NE: norepinephrine.Chiropractic & Osteopathy 2006, 14:25 http://www.chiroandosteo.com/content/14/1/25
Page 4 of 13
(page number not for citation purposes)
PVN has been implicated in a variety of behaviors includ-
ing feeding, thirst and cardiovascular mechanisms as well
as in the organization of autonomic and endocrine
responses. The arcuate nucleus projects to preoptic LHRH
neurons, and is involved in the regulation of gonado-
trophin secretion and sexual behaviour during the female
reproductive cycle. The dorso-lateral hypothalamic nuclei
project fibres to lateral parts of the brain stem, with
numerous fibres terminating in the caudal brainstem lat-
eral tegmentum, including the locus coeruleus, parabra-
chial nuclei, nucleus subcoeruleus, and the solitary and
dorsal vagal nuclei [24].
With arrangements of ascending and descending fibres
from various areas including the limbic system, medial
hypothalamus, and the autonomic nervous system, the
hypothalamic system is able to exert effects on the neuro-
endocrine and neuronal pathways, as well as indirect
influences to the periphery, playing an extremely impor-
tant role in mediation of the stress response.
Limbic afferents
The limbic system is located in the boundary between the
telecephalon and the diencephalon. Environmental stim-
uli, posing as external stressors, are recognized by specific
sensory receptors systems, which transmit information via
the nucleus of the solitary tract to respective sensory areas
of the thalamus from spinal or cranial sensory neurons.
These inputs include mechanoreceptors. [25]
Sensory information is transmitted to the amygdala
through direct thalamo-amygdala connections, or indi-
rectly though thalamo-cortico-amygdala connections
[27]. The lateral nucleus of the amygdala receives and
processes information from both pathways, and then
projects to central, basal and basal accessory nuclei of the
amygdala [28], as well as to the hippocampus, orbitofron-
tal cortex, cingulate [29] and via the reticular activating
system to the sensory cortex [30,31]. The sensory cortex
then directs information directly to the amygdala, or via
the hippocampus and then to the amygdala. [32].
The hippocampus does not receive information involving
individual sensory stimuli, but more general contextual
cues [27]. Contextual cues can be seen as tasks performed
in a predefined movement. When a cue is available, the
motor system forms an internal model that uses both
serial order and target direction to program motor com-
mands [33]. The hippocampus thereby receives informa-
tion on a universal basis, participating in declarative
memory function, and integrating important contextual
elements such as the time and place of events. This is
important for retrieval and utilization of stored informa-
tion into the future [29]. External stimuli present informa-
tion to sensory processing systems of the neocortex, which
creates a memory context through primary and higher
order sensory cortices [27]. These systems project to asso-
ciation cortices, such as the parieto-temporo-occipital and
prefrontal, and then to the transitional cortex, including
entorhinal, parahippocampal and perirhinal areas of the
limbic system, where different memory contexts are incor-
porated. The entorhinal cortex projects these incorporated
contexts to the hippocampus where even more complex
contexts are established [34]. Back through the same path-
ways, the hippocampus projects to the neocortex and for-
ward to the amygdala and paraventricular nucleus (PVN)
of the hypothalamus [30]. Retrieval and utilization of
stored information is carried out through the hippocam-
pus and other related cortical areas, and projected to the
amygdala, which may trigger a stress response of context
memories, even without external events [35].
Limbic efferents
Individual stimuli presenting as external stressors, or
emotional evaluation of internal stressors are fundamen-
tally analyzed by the amygdala [34]. Therefore the central
nucleus of the lateral amygdala is involved in the coordi-
nation of stress behaviour and modulating memory con-
solidation [6], as well as controlling neuroendocrine and
autonomic responses [36,37]. The regulation of these sys-
tems occurs through numerous connections including
direct projections through the bed-nucleus of the stria ter-
minalis to the hypothalamus [8], which projects to the lat-
eral hypothalamus to mediate the activation of
sympathetic component of the ANS [36]; projections to
the dorsal motor nucleus of the vagus are involved in the
activation of the parasympathetic component of the ANS
[37]; projections to the NLC and ventral tegmental area
are involved, respectively in the activation of the
noradrenergic and dopaminergic systems [38] and projec-
tions to the midbrain central gray mediate certain behav-
ioural responses and importantly direct projections to the
PVN of the hypothalamus [39].
The hippocampus also regulates the neuroendocrine
stress response by inhibition of the HPA axis through glu-
cocorticoid negative feedback [40]. Network functions
within the hippocampus are altered by persistent corticos-
teroid actions, resulting in decreased accuracy and relia-
bility of contextual memories [6]. In a situation where a
decision needs to be made whether or not there is a stress,
this decreased accuracy and reliability prevents access to
important information. The amygdala has neuronal pro-
jections to the paraventricular nucleus of the hypothala-
mus, and this amygdalo-hypothalamic pathway is
believed to influence the activity of the neuro-endocrine
hypothalamic-pituitary system, and behavioural func-
tions under a range of physiological conditions [41]. This
amygdalo-hypothalamic pathway is believed to performChiropractic & Osteopathy 2006, 14:25 http://www.chiroandosteo.com/content/14/1/25
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an essential role in the adreno-cortical response to a
number of somatosensory stimuli [42].
Thus, the limbic system is actively involved in the body's
stress response and this stress response is affected by
memory and emotion. It is important these interactions
are considered in terms of the known associations of
chronic pain and psychosocial variables [43-45]. It is
likely that such associations should receive greater atten-
tion in diagnosis and treatment by chiropractors, particu-
larly those managing chronic pain syndromes. New
techniques such as the neuroemotional technique (NET)
that claim to consider such variables in the diagnosis and
management of pain should endeavour to measure varia-
bles of the stress response to support rhetoric that their
management approaches can manage chronic pain and
disease by the application of techniques associated with
cognitive and behavioural principles.
Neurobiology
Mechanisms used by the body to respond to stressful
stimuli are illustrated below. The intricate biology of the
stress response is depicted via numerous pathways work-
ing together to function at a systemic level. These systems
are activated under different mechanisms, controlling
areas of the body as means of survival. The principal phys-
iological responses to stress are mediated by the sym-
pathoadrenal system, and the hypothalamo-pituitary-
adrenal axis [46].
Sympatho-Adrenal System (SAS)
The autonomic nervous system is a rapidly responding
mechanism, controlling numerous systems including car-
diovascular, gastrointestinal, respiratory, renal and endo-
crine which are under control of the sympathetic,
parasympathetic or both nervous systems [47]. Activation
of the SAS system functions to reduce blood flow, reduce
activity of the gastro-intestinal system and reproductive
organs, as well as mobilise energy to the brain, heart and
muscles [48]. It does this via synapses of sympathetic pre-
ganglionic fibres in the intermediolateral column of the
spinal cord with the postganglionic sympathetic neurons
innervating the smooth muscle [49]. This evolutionary
mechanism has evolved to create quick compensatory
changes in homeostasis for intense physical activity, by
increasing the capacity of the 'fight or flight' reaction and
therefore promote survival.
During an antecedent event, activation of the SAS system
(locus coerulus/norepinephrine/sympathetic nervous sys-
tem) evokes the release of noradrenaline and neuropep-
tide-Y from postganglionic nerve terminals, while
preganglionic innervation of the adrenal medulla results
in an increased secretion of adrenaline and dihydroxyphe-
nylaline (DOPA) [50]. Activation also results in the
increased secretion of Interleukin-6, an important
cytokine that connects the stress system and various
immunological and inflammatory processes [6].
Hypothalamic-Pituitary-Adrenal Axis (HPA Axis)
The hypothalamo-pituitary-adrenocortical (HPA) axis
plays a fundamental role in adaptation of the organism to
homeostatic challenge, and should be thought of as the
body's energy regulator, as it is ultimately responsible for
controlling virtually all of the hormones, nervous system
activity, and mineral homeostasis [13]. Activation of the
HPA system results in secretion of glucocorticoids, which
act at numerous levels to redirect bodily energy resources
[51]. These hormones are recognized by glucocorticoid
receptor molecules in numerous organ systems, and act by
genomic mechanisms to modify transcription of key reg-
ulatory proteins [51].
The HPA axis is readily activated by stressful stimuli [46].
Sensory information reaches the cortex via the thalamus
and is conveyed to the central amygdaloid nucleus of the
amygdala [8]. It responds by providing the stimulus to
cortico-releasing hormone (CRH) neurons in the paraven-
tricular nucleus of the hypothalamus to increase the secre-
tion of principal neuropeptide CRH and arginine
vasopressin (AVP) into the hypophyseal portal blood-
stream. These secretions are thence transported to the
anterior pituitary gland [52]. The corticotrophin produc-
ing cells of the anterior pituitary synergise CRH and the
AVP through CRH-RI and VIb receptors respectively to
increase expression of the adreno-corticotropin hormone
(ACTH) precursor, and further promote the release of
ACTH into the systemic circulation [53]. Upon release,
ACTH stimulates the zona fasciculata cells of the adrenal
cortex to release synthesized glucocorticoid (cortisol in
humans) and mineralocorticoid hormones (principally
aldosterone) [54,55]. Via a delicate negative feedback
loop, glucocorticoids control the termination of the stress
response via inhibitory control of the production and
release of CRH and ACTH at the level of the hypothala-
mus and pituitary respectively, via transmitter systems
projecting to the hypothalamus [56]. Glucocorticoids
activate steroid receptor mediated transcriptional regula-
tion and membrane receptors, inducing changes which
serve to mobilize energy and inhibit other potentially
costly reactions to stress. Glucocorticoids promote gluco-
neogenesis, increase blood pressure and suppress aspects
of immune and reproductive function [57]. In addition
Inhibition of the ACTH response occurs through the glu-
cocorticoids binding to receptors in the hippocampus,
which control CRH production and limiting the period of
exposure to the stress response, therefore minimizing the
catabolic immunosuppressive and anti-reproductive
effects of glucocorticoids [6].Chiropractic & Osteopathy 2006, 14:25 http://www.chiroandosteo.com/content/14/1/25
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Catecholamines are involved in these pathways as chemi-
cal messengers. Brainstem catecholaminergic and non-
catecholaminergic neurons, through collateral branching
inputs may provide coordinated signaling of visceral
input to rostral forebrain sites. This may lead to a synchro-
nized response of the CNA and PVN for the maintenance
of homeostasis [58]. Thus, emotion and memory effects
mediated via these centres have the potential to cause dys-
functioin in the viscera. Such dysfunction should be con-
sidered in the management of chronic pain and disease
states
Magno- and Parvo- cellular system
The magnoceullular neurons of the supraoptic (SON) and
PVN, along with scattered clusters of cells between the two
nuclei, comprise the hypothalamo-hypophyseal system.
These cells send oxytocin and vasopressin containing
fibres to the posterior pituitary where these substances are
released into the peripheral circulation. Vasopressin is an
antidiuretic hormone (ADH) and is released in response
to changes in osmotic pressure of circulating blood or
extra-cellular space. ADH controls water balance, in par-
ticular retention of water regulated in the distal tubules of
the kidneys.
Implications of the stress response on the body
Everyday interactions with the environment inevitably
expose the body to a wide range of stressful stimuli. The
stress response has evolved for efficient functioning of the
neuro-endocrine and neuronal pathways to play a vital
role in adaptation of the body to homeostatic challenges
brought to bear on it. It is during times of repeated,
chronic activation that dysregulation of the stress
response may lead to manifestation of disease of the
body. Chronic stress may lead to physiological systems
within the brain and body fluctuating to meet internal or
external demands, causing deterioration, and leading to
maladaption [10]. Physiological systems such as the cen-
tral nervous system, reproductive system, cardiovascular
system, metabolic system and immune system are all
involved in survival and adaptation. When stress cannot
be normalised (enabled, disabled or decreased), it may
become detrimental to health. The detrimental effects of
stress may manifest in several system wide disorders such
as: behavior/mood disorders of substance abuse and
depression [59,60]; cardiovascular disorders such as
hypertension, atherosclerosis and cardiovascular disease
[61]; metabolic diseases such as insulin resistance/meta-
bolic X syndrome and obesity ([52]; immune disorders
that include chronic inflammatory processes, autoim-
mune diseases [62]; or vulnerability to these or other dis-
eases [63]. Thus, inefficient activation of the stress system
may have destructive effects bodily functions and these
effects may contribute to the onset and maintenance of
organ/tissue dysfunction.
Glucocorticoids
Glucocorticoids, adrenal hormones secreted during stress,
are seen as key hormones, which are able to permit, stim-
ulate or suppress the stress response [52]. The primary glu-
cocorticoid in humans, cortisol, is secreted continuously
by the adrenal cortex in a diurnal pattern, with early
morning peaks and evening troughs, but secretion can
increase dramatically in the dynamic setting of environ-
mental stressors. Its secretion can adversely affect many
bodily functions [7]. Glucocorticoids restrict circulating
CRH and ACTH levels, preventing inappropriate steroid
exposure following a brief episode of stress. Network
functions within the hippocampus are disturbed by per-
sistent glucocorticoid activation, triggering secretion out-
side the normal physiological range, resulting in atrophy
of the human hippocampus [64], and alteration of net-
work functioning [65]. Damage associated with changes
in the regulation of the HPA axis cause deficits in memory,
cognition and learning [30], and decreased accuracy and
reliability of contextual memories [6], thus contributing
to behavioural adaptations to the response to stress. Pro-
longed elevations of glucocoticoid levels cause diseases
such as Cushings Syndrome [67], or contribute to precip-
itation of disease such as major depressive disease [10],
Alzhimers Disease [66], post-traumatic stress disorder
[68] and recurrent depressive illness [62].
Uno et al. [69] provided the first evidence that chronic
stress resulted in glucocorticoid hypersecretion, resulting
in neurodegeneration of the primate after a retrospective,
neuropathological study was performed on eight vervet
monkeys. At death the monkeys were found to have mul-
tiple gastric ulcers. Compared with controls euthanized
for other research purposes, ulcerated monkeys had
marked hippocampal degeneration that was apparent
both quantitatively and qualitatively, and was detected
both ultrastructurally and at light-microscopic level. It
was discovered that in ulcerated monkeys which appeared
to have been subject to sustained social stress, perhaps in
the form of social subordinance in captive breeding
groups, and which also had had significantly high inci-
dences of bite wounds at death, these monkeys had hyper-
plastic adrenal cortices, indicative of sustained
glucocorticoid release [69].
Excess glucocorticoids, as the end effect of chronic stimu-
lation of the HPA axis, may constitute a base for patho-
physiological consequences in the periphery of the body.
This includes potentiation of sympathetic nervous sys-
tem-mediated vasoconstriction, proteolysis and lipolysis
[70], energy mobilization (glycogenolysis) in the liver
[41], and processes such as reproductive, metabolic and
immune functions. Many such changes have often been
attributed to spinal based reflex changes associated with
chronic somatic dysfunction.Chiropractic & Osteopathy 2006, 14:25 http://www.chiroandosteo.com/content/14/1/25
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Reproductive function
Systems activated by stress can influence reproduction at
the hypothalamus, pituitary gland or gonads. There are
close relations with the sustained activity of the end-prod-
uct of the HPA axis and suppressed steroid sex and growth
hormones [57]. The first wave of hormonal mediators of
the stress response stimulates the production of hypotha-
lamic CRH, which inhibits gonado-tropin releasing hor-
mone (GnRH). Via the release of somatostatin,
hypothalamic CRH also inhibits growth hormone (GH),
thyrotropin-releasing hormone (TRH) and thyrotropin
secreting hormone (TSH) secretion thereby suppressing
growth, reproduction, and thyroid functions [71]. Gluco-
corticoids directly inhibit the pituitary gonadotropin, GH
and TSH secretion, causing target tissues of sex steroids
and growth factors to become resistant [7]. Increased glu-
cocorticoid secretion significantly reduces peak luteiniz-
ing hormone (LH) inhibiting the effect of glucocorticoids
on the pituitary gonadotroph [72]. Furthermore, suppres-
sion of the growth, reproduction and thyroid functions
arises from glucocorticoid ability to suppress the 5' deio-
dinase, which functions to convert virtually inactive tetra-
iodothyronine (T4) to triiodothyronine (T3) thereby
causing s stress induced state of hypothyroidism [73].
The female reproductive system is regulated by the
hypothalamic-pituitary-ovarian axis. The principal regula-
tor of the hypothalamic-pituitary-ovarian axis is GnRH
[74]. GnRH stimulates pituitary follicle stimulating and
LH secretion and, subsequently, estradiol and progester-
one secretion by the ovary. When activated by stress, the
HPA axis exerts an inhibitory effect on the female repro-
ductive system. CRH and CRH-induced proopiomelano-
cortin peptides such as β-endorphin inhibit hypothalamic
GnRH secretion [75]. In addition, glucocorticoids sup-
press gonadal axis function at the hypothalamic, pituitary
and uterine level [44,76]. Furthermore, glucocorticoids
inhibit estradiol-stimulated uterine growth [76]. These
effects of the HPA axis are responsible for the "hypotha-
lamic" amenorrhea of stress, which is observed in anxiety
and depression, malnutrition, eating disorders and
chronic excessive exercise, and the hypogonadism of the
Cushing syndrome [77]. On the other hand, estrogen
directly stimulates the CRH gene promoter and the central
noradrenergic system [50], which may explain women's
mood cycles and manifestations of autoimmune/allergic
and inflammatory diseases that follow estradiol fluctua-
tions.
Metabolic function
Stress is understood to contribute to the pathogenesis of
disease, and under chronic conditions contributes to dis-
ease by impairing the body's ability to correctly control
normal responses of the body. Increased glucocorticoid
secretion causes resistance of growth hormone from oste-
oblastic cells of bones, inhibiting osteoblastic activity that
renders them osteoporotic [73]. Chronic activation of the
stress response can lead to the promotion of visceral adi-
posity, and is achievable by glucocorticoids stimulating
hepatic gluconeogenesis, and inhibiting insulin activity
on skeletal muscles and adipose tissue respectively [7]. In
the abdominal region, fat cells have a higher density of
corticosteroid receptors, with cortisol increasing receptor
sensitivity metabolism of target fat cells, thereby increas-
ing the storage of fat in this area [79]. Furthermore,
chronic stress suppresses growth hormone, leutinising
hormone, testosterone, TSH and T3 instigating insulin
resistance/hyperinsulinemia and dyslipidemia [80]. This
leads to the exertion of a complex and long-lasting effect
involving increased SNS activity and increased cortisol
and epinephrine secretion which influences non-genetic
factors on the origins of type I diabetes [81] and hampers
the control of Type I and Type II diabetes [82]. Here we see
a demonstration of the manifestation of the "Metabolic
Syndrome". As discussed by Chrousos [7] and Girod and
Brotman [83], situations associated with chronic activa-
tion of the HPA axis may derive some of their associated
cardiovascular risk from untoward glucocorticoid effects,
leading to myocardial infarction and atherosclerosis.
Raadsheer et al., [84] investigated higher circulating glu-
cocorticoid levels, and impaired suppression of cortisol in
depressed patients and found that many exhibited symp-
toms of increased glucocorticoid tone as discussed above,
such as central obesity, menstrual irregularity, immuno-
suppression and osteoporosis. Chrousos [6] stated that
stress-induced hypercorticolism, visceral obesity, and
other related sequelae have the potential to increase the
all-cause mortality of affected subjects by 2–3 times, and
shorten life expectancy by several years.
Immune disorders
Glucocorticoids have been clinically used to control
autoimmune disease, and inflammation, as well as organ
donation rejection for many decades [85]. The role of glu-
cocorticoids is to inhibit the production of proinflamma-
tory cytokines such as tumor necrosis factor (TNF)-A,
interferon (IFN)-Y and interleukin-12 (IL-12), and to
stimulate the production of anti-inflammatory cytokines
such as IL-10, IL-4 and transforming growth factor (TGF)-
B [86]. During chronic inflammatory stress, interleukin-6
(IL-6) plays a major role of the endocrine cytokines in the
immune stimulation of the HPA axis [73]. Chronic activa-
tion of the stress response has been found to impair
immune functions, and delay the healing process [79].
The role of the HPA axis is crucial to regulating the severity
of autoimmune disease, though the cause remains
obscure. In the absence of corticosteroids the immune sys-
tem is unrestricted and its activation by either acute or
chronic immune challenge is likely to be fatal [87].Chiropractic & Osteopathy 2006, 14:25 http://www.chiroandosteo.com/content/14/1/25
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Neuromuscular disorders
Predictable disorders such as low back pain, tension head-
ache and even rheumatoid arthritis may be a result of
repeated activation of postural musculature during
chronic flight-or-flight responses [88]. Jacobson [89] first
argued that proprioceptive impulses could be found in
conditions of high musculoskeletal tension. It was
hypothesized that if such tension was combined with
high levels of sympathetic activity, it could contribute to
anxiety reactions. Krantz et al. [90] investigated different
physiological responses to stress, as well as surface electro-
myography of the trapezius muscle. They found signifi-
cant association between sympathetic arousal and
electromyography activity, which is of importance when
understanding the relation between musculoskeletal dis-
orders and stressful situations. This is of particular interest
in the treatment of work-related pain disorders in psycho-
social stress syndromes as they may cause the develop-
ment of pain disorders [91,92]. Therefore, chiropractors
may require additional interventions to manage all
aspects of chronic pain syndromes presenting to them.
Combined psychological and manual interventions may
provide the most appropriate healing of chronic condi-
tions of the musculoskeletal neurohormonal systems
commonly associated with chronic stress and disease. Fur-
ther research is needed on the physiological and psycho-
logical effects of stress and its manifestation on the
musculoskeletal system, as well as the effects of manipu-
lative treatment on physiological and psychological func-
tions. Emphasis should be given to the potential
measurement of the stress response on various bodily sys-
tems after the application of manipulative therapy in nor-
mal and disease states.
Relevance to chiropractic
Chiropractors treat conditions of a neuromusculoskeletal
and non-neuromusculoskeletal nature [93]. The majority
of conditions treated by chiropractors are neuromuscu-
loskeletal [94]. Much controversy exists about the role of
chiropractic in the management of the non-neuromuscu-
loskeletal conditions [95]. These non-neuromusculoskel-
etal conditions are sometimes referred to as "type O"
conditions and the neuromusculoskeletal conditions are
sometimes referred to as "type M" conditions. To justify
the relevance of the management of the "type O" condi-
tion, the chiropractic profession has usually cited the pres-
ence of the somatovisceral and viscerosomatic reflexes as
being integral to both the cause and potentially the man-
agement of the "type O" disorder [96,97]. Despite this
dependence on the existence of these reflexes to justify a
philosophical approach to management, little evidence
exists to warrant the continued support of this justifica-
tion.
The literature supports the existence of somatovisceral
and viscerosomatic reflexes [98-100], but there is little or
no evidence to support the notion that the spinal derange-
ments (often referred to as subluxations by chiropractors)
can cause prolonged aberrant discharge of these reflexes.
Equally unsupported in the literature is the notion that
the prolonged activation of these reflexes will manifest
into pathological state of tissues, and most relevantly, that
the application of spinal manipulative therapy can alter
the prolonged reflex discharge or be associated with a
reversal of the pathological degeneration of the affected
reflexes or tissues [101,102]. The evidence that has been
amassed is largely anecdotal or case report based [102-
104] and it has attracted much intra disciplinary debate
[102,105,106] because of its frequent association with
certain approaches to management (largely described as
being traditional or "philosophical" in nature).
Traumatic stress of a physical nature is known to manifest
in changes to limbic, memory and other relevant stress
centres in the brain including the hypothalamus and pitu-
itary [107]. Whilst still controversial in management and
diagnosis [108] conditions such as post traumatic stress
disorder may be the linking mechanism for the manifesta-
tion of psychosocial variables often noted by chronic pain
researchers [109-113]. If this supposition is true, would a
purely mechanistic treatment approach be appropriate for
its cost effective management?
Despite prolonged debate, very little consideration has
been given to other potential mechanisms (and solutions)
for the presence (and resolution) of the "type O" condi-
tion. A recent review has detailed that the somatovisceral
reflex is a short term effect (millisecond to seconds in
duration) when compared to supraspinal influences on
the spinal cord which can be weeks to months in duration
[102]. The review reasoned that the chiropractic profes-
sion should consider supraspinal factors in the generation
and management of chronic pain states [102]. This con-
clusion is particularly pertinent on the now known asso-
ciation of psychosocial variables in chronic pain and
disease [102], and the fact that many of the conditions
treated by chiropractors whether type O or M are of a
chronic nature [95]. However, the call to look at non-spi-
nal non mechanical aspects of management has not been
well received by the profession to date as evidenced by the
continued predominantly mechanistic approach to man-
agement.
Chronic pain is associated with stress [114]. It is a matter
of fact that stress can affect multiple systems within the
body [115], including the neuromusculoskeletal system
("type M" disorders) [101] and the non-neuromusculosk-
letal systems ("type O" disorders) [101].Chiropractic & Osteopathy 2006, 14:25 http://www.chiroandosteo.com/content/14/1/25
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As with all homeostatic function, individual functions
often have an optimum range of function outside of
which function is decreased or becomes pathological.
Thus, it is plausible that too little or too much of a partic-
ular function may be detrimental to the optimal function
of the organism. Chronic stress is associated with abnor-
mal organ function and the presence of disease [116,117].
Removal of stress has been shown to rehabilitate stress
induced disease [118]. Can the chiropractic treatment
(spinal manipulative therapy or adjustment) reduce stress
levels as a potential mechanism for improvement of the
"type M" or "type O" disorders? Are the newer techniques
such as neuroemotional technique [119] that incorporate
elements of cognitive/behavioural principles, Pavlovian
conditioning and repetition compulsion with spinal
manipulative therapy effective in altering stress associated
with stress related disorder? Is any potential reduction
associated with peripheral or supraspinal mechanisms of
action? Can the profession adapt to its primarily mecha-
nistic paradigm to truly incorporate the biopsychosocial
model of disease first proposed by Engel in the 1970's
[120].
Stress as a mechanism of system wide disease
It seems reasonable to examine physiological systems
involved in the processing of symptoms such as pain in
the many conditions reported to be managed by chiro-
practic intervention strategies. Whilst the somatoviseral
reflex has been used as an example of a possible mecha-
nism for the cause and management of these conditions,
the scope of conditions that cannot be addressed by this
mechanism is still large. We contend that a higher centre
system impacting on the spinal cord could better explain
the diversity of conditions.
In doing so, a consideration should be given to the role of
psychosocial variables resulting from the stress of various
events including trauma [121]. Findings from animal
studies have interestingly suggested that hormones of the
HPA axis, pain-processing pathways, and autonomic nerv-
ous system may be underlying peripheral as well as central
substrates of chronic pain and broad system dysfunction
[122,123]. Traumatic physical or psychological stress can
have enduring impact on functioning of these systems,
and chiropractors manage conditions incorporating ele-
ments of these systems [124]. An impaired HPA axis could
serve as a physiological mechanism of medically unex-
plained symptoms as well as function as a mediator
between psychological distress and observed symptoms
[125].
Chiropractic management of non-musculoskeletal conditions
Chiropractic management strategies have been used to
manage or co-manage a number of non-musculoskleletal,
non-malignant conditions. The pubmed database was
searched in June of 2006 with the terms "chiropractic"
and "case" and returned more than 589 hits. Of these,
more than 40 related to non-musculoskeletal care. Some
examples included: Ehlers-Danlos syndrome [126], gas-
troesophageal reflux [127], cervical spinal cord compres-
sion[128], congestive heart failure [129], asthma [130],
cervical dystonia [131], ulnar tunnel syndrome [132] and
myaesthenia gravis [133]. Unfortunately more examples
of complications were returned in the pubmed database
with this search string than there were examples of non-
musculoskeletal treatment. The ratio appeared to be at
least 3 to one.
By contrast, 416 hits were returned from the same search
string on the Index to Chiropractic Literature database
(ICL). There appeared to be fewer reports of negative out-
comes, and the scope of the reports appeared just as broad
as that presented on the Pubmed databases. Some exam-
ples include: otitis media [134], post polio syndrome
[135], urinary incontinence [136], Dejerine-Roussy syn-
drome [137] and infantile colic [138].
It appears that the two databases present very different
perspectives based on the content of their contributing
journals, one (Pubmed) largely a medical database and
the other largely chiropractic (ICL). This differential may
explain and or reflect the different perspectives that chiro-
practors hold with regard to the management of non-mus-
culoskeletal conditions when compared with their
medical counterparts.
As mentioned previously, chiropractic often postulates
the somatovisceral reflex as being the vehicle for the
changes noted in the above conditions [101]. However,
less speculation is given to the potential role of supraspi-
nal or cortical processes in the etiology and management
of such conditions. As a large body of research currently
supports the role of psychosocial variables in the genera-
tion and maintenance of disease [139-145], chiropractic
should look to this research to potentially explain some of
the clinical observations being made and recorded in the
journals.
A review by Siegrist and Marmot discusses psychosocial
variables as causative, aggravating, and perpetuating fac-
tors for the stress response, as well as stress implicating
elevated psychosocial variables [146]. The stress response
has been associated with the propagation of numerous
disorders including: dermatological [147], cardiovascular
[148,149], diabetic [150], Hepatic [151], immune [152],
thyroid [153], gastrointestinal [154,155], reproductive
[156-158], renal [159], metabolic [160], rheumatic [161]
and musculoskeletal [162,163].Chiropractic & Osteopathy 2006, 14:25 http://www.chiroandosteo.com/content/14/1/25
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Future studies could utilize a randomized controlled trial
design and measure variables such as: self reported levels
of pain, disability, anxiety, depression, as well as objective
blood and urine based measures of stress including:
proinflammatory cytokines (TNF-alpha, IL-1, IL-6, IL-8,
IL-18) [121,164,165] and anti inflammatory cytokines
such as IL-4 and IL-10 [122,165,166]. These tests could be
cross-referenced to the expression of collagen expressed in
the inflammatory reaction frequently associated with
chronic disease. Research designs such as the above would
provide information on the effect of chiropractic manage-
ment on subjective variables of pain as well as objective
measures of stress and provide insight into the mecha-
nism of action. It is only with similar studies can the asso-
ciation of stress be investigated thoroughly and its
relevance to chiropractic measured accurately.
Conclusion
Sufficient evidence exists to consider stress and its mecha-
nism, in the generation of diseases often seen by chiro-
practors. To date little investigation of this potential
mechanism of disease and treatment has been conducted
by the chiropractic profession. In a time when peak chiro-
practic organizations are calling for a mind-body
approach to the management of chronic musculoskeletal
and non – musculoskeletal disease [165], due considera-
tion of the body of neurobiological evidence that supports
the broadening of the operating paradigm within chiro-
practic seems warranted. Despite the call for a broadening
of approaches and the embrace of such approaches by
groups within chiropractic, it appears the threat to the
dominant paradigm appears too great for most to adapt.
The profession should consider more closely the emerging
areas of study such as psychoneuroimmunology and how
the development of that literature actually supports a
broadening of the dominant mechanistic paradigm to
reflect recent advances in science.
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